An open-label phase I dose-finding study of APR-246 in hematological malignancies
Stefan Deneberg(Karolinska University Hospital), Sören Lehmann(Uppsala University), Honar Cherif(Uppsala University Hospital), Gunnar Juliusson(Lund University), Mia von Euler(University Hospital of North Norway), Vladimir Lazarević(Skåne University Hospital), P-O Andersson(Södra Älvsborg Hospital)
Cited by 85
Related Papers
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k
Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized Trial
|Journal of Clinical Oncology|2000|996
Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
|Journal of Clinical Oncology|2000|840
Reappearance of Hippocampal CA1 Neurons after Ischemia is Associated with Recovery of Learning and Memory
|Journal of Cerebral Blood Flow & Metabolism|2005|169